[Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
D000368:Aged; D001545:Benserazide / Q000627:therapeutic use; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004338:Drug Combinations; D004361:Drug Tolerance; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*
D004338:Drug Combinations; D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D002262:Carboxy-Lyases
L'associazione terapeutica L-dopa-inibitore della decarbossilasi periferica nel parkinsonismo. Risultati preliminari.